Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Not-So-Quick Fix: ADHD Behavioral Therapy May Be More Effective Than Drugs, Says Child Development Institute.

 



(Medical-NewsWire.com, June 06, 2012 ) Orange, CA -- The recent article was based on findings of the April 2012 Experimental Biology meeting held in San Diego. At the conclusion of the meeting a consensus opinion was formed based on a new synthesis of behavioral, cognitive and pharmacological findings. According to Scientific American summary, the basic conclusion was:



“Behavioral and cognitive therapies focused on reducing impulsivity and reinforcing positive long-term habits may be able to replace current high doses of stimulant treatment in children and young adults”.



However, this does not mean that all children, teens and adults with a diagnosis of ADHD can be successful in life without taking any medication. The conclusion instead suggests that a combination of lower doses of medication combined with behavioral and cognitive therapy may produce better long-term benefits than medication alone.



In fact, independent research and current professional guidelines for the treatment of ADHD in children suggest that individuals with mild to moderate symptoms should be started on psychological treatment first with medication added only if needed after an adequate trial on the behavioral and cognitive interventions.



The article ends with a note of caution:



“The trick will be identifying which of the new therapies is most effective, and making those therapies affordable. For now, stimulant medications are much cheaper and act faster than behavioral therapy, even if the latter may be the most effective in the long run. But experts as well as parents know that the long run is what matters most.”



One possible solution that thousands of parents have turned to is Total Focus - a comprehensive, multimedia, home-use treatment program using behavioral and cognitive interventions that have been found to be effective by scientific research.



The program was developed by child psychologist Robert Myers and is based on a successful outpatient group treatment program developed for a regional health plan in California.



After a thorough review of the program, a recognized ADHD researcher concluded, “In a nutshell, I am most impressed with this program, which incorporates a wealth of extremely helpful information and programming, derived largely from evidence-based practice presented in an extremely user-friendly format for the families of children with Attention Deficit Disorder (ADD)”.



The program costs less than one visit to a mental health professional or around two months on many common ADHD medications.



The ADD behavioral program provides parent education, a behavior modification program, cognitive behavioral therapy, relaxation-biofeedback training, social skills training and brain training (cognitive rehabilitation exercises) and many other useful resources.



It ensures that Parents and children work as a team to produce positive changes in behavior at home and at school, as well as achieve improved academic potential.



More information about the Total Focus ADD Behavioral Program can be found here.





******

About Total Focus:



Total Focus is a multi-media program that provides what health professionals refer to as Evidence-based Treatment (based on scientific research).



The program is delivered via a CD with an interactive workbook, daily success charts for teachers and a handy “stress meter” to help every child recognize when he’s “over the top” and stay calm under stress. The program works with both parents and their children.



Both the American Academy of Pediatrics (AAP) and the American Academy of Child & Adolescent Psychiatry (AACAP) professional guidelines for best practice treatment of ADHD / ADD state that medication should be used in conjunction with psychological interventions for best over-all results.



The guidelines also state that for children with mild to moderate ADHD symptoms, it may be advisable to try psychological interventions first before adding medication.



Total Focus

Robert Myers, PHD

robertm@childdevelop

info@10acne.com

Source: EmailWire.Com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo! News
Health News Headlines - Yahoo! News
Get the latest health news headlines from Yahoo! News. Find breaking health news, including analysis and opinion on top health stories.


Birth control coverage up for federal appeal
23 May 2013 at 12:58am

DENVER (AP) ? In the most prominent challenge of its kind, Hobby Lobby Stores Inc. is asking a federal appeals court Thursday for an exemption from part of the federal health care law that requires it to offer employees health coverage that includes access to the morning-after pill.



Nearly all US states see hefty drop in teen births
22 May 2013 at 9:23pm

NEW YORK (AP) ? The nation's record-low teen birth rate stems from robust declines in nearly every state, but most dramatically in several Mountain States and among Hispanics, according to a new government report.



Doctors save Ohio boy by 'printing' an airway tube
22 May 2013 at 3:09pm

In a medical first, doctors used plastic particles and a 3-D laser printer to create an airway splint to save the life of a baby boy who used to stop breathing nearly every day.


J&J plans filing on more than 10 new drugs by 2017
23 May 2013 at 5:31am
(Reuters) - Johnson & Johnson said on Thursday it plans to submit more than 10 new products for regulatory approval by 2017, including drugs to treat hepatitis C, immune diseases and schizophrenia, and vaccines for flu, rabies and polio. It said products launched since 2009 will account for nearly half of its pharmaceutical sales by 2017. It also said it plans to continue developing its pipeline of new development-stage drugs in Japan and China, where it also has drugs in later stages of development. ...

Saudi Arabia confirms another death from SARS-like virus
23 May 2013 at 5:11am
DUBAI (Reuters) - Saudi Arabia has announced another death from the SARS-like novel coronavirus (nCoV) in its central al-Qassim region, bringing the total number of deaths in the kingdom to 17. A non-Saudi, whose nationality and age were not given, died on Tuesday, the Health Ministry said on its website late on Wednesday. It said he had been admitted to a hospital in al-Qassim several days ago with an "acute respiratory syndrome". "Most cases recorded so far are among elderly patients and people with multiple chronic diseases," it added. ...

BTG says interventional medicine buys could boost sales to $1 bln
23 May 2013 at 5:07am
By Paul Sandle LONDON (Reuters) - British pharmaceutical company BTG announced two deals on Thursday that it said could create an interventional medicine business with potential sales of $1 billion. Chief Executive Louise Makin told Reuters the deals would more than double BTG's revenues in the fast-growing market of targeting specific areas rather than administering drugs to the whole body. BTG added to its liver cancer treatments by agreeing to buy the targeted therapies division of Nordion Inc for about $200 million, adding Therasphere radioactive glass beads to its chemotherapy beads unit. ...

Ala. Mystery Illness May Be Coincidence
23 May 2013 at 4:40am
A mystery illness has sickened seven people in southeastern Alabama, killing two of them, according to the state Health Department, but it's not clear whether the patients ? or their symptoms ? are connected.        

GSK flu shot may raise adult narcolepsy risk: Finnish scientists
23 May 2013 at 4:13am
HELSINKI/LONDON (Reuters) - GlaxoSmithKline Plc's H1N1 pandemic flu shot may put adults at higher risk of developing narcolepsy, not only children as previous studies found, Finland's National Institute for Health and Welfare said on Thursday. Growing evidence of a link between GSK's Pandemrix vaccine and an increase in narcolepsy, a rare sleep disorder, among children who received it in Europe has delayed approval of a similar vaccine in the United States. ...

Watch: Mystery Illness Kills 2 in Alabama
23 May 2013 at 4:02am
Five people are still hospitalized for respiratory illness.        


Lawyers in Colorado shooting case to challenge insanity defense law
23 May 2013 at 3:31am

By Keith Coffman DENVER (Reuters) - Public defenders representing James Holmes, accused of killing 12 moviegoers in Colorado last summer, will return to court on Thursday to challenge the state's insanity defense law in a bid to try to avoid the death penalty for their client. Lawyers representing Holmes, 25, are challenging Colorado's capital punishment statute on several fronts, and on Thursday are arguing that it unconstitutionally bars him from calling his own mental health experts at sentencing if he refuses to cooperate with court-appointed psychiatrists. ...


Can You Do Yoga if You Aren't Flexible?
23 May 2013 at 3:00am
I always thought that of yoga as something only done by young, lithe ballet enthusiasts. It was definitely not something practiced by uncoordinated, middle-aged guys who can?t touch their toes. Put me in the latter category and add to that that I?m nearly six-and-a-half feet tall and have had two back...        

BTG builds interventional medicine platform with deals
23 May 2013 at 12:01am
LONDON (Reuters) - Britain's BTG said it would make two acquisitions, one extending its expertise in liver cancer and the other a treatment for severe blood clots, to create an interventional medicine business with potential sales of $1 billion. The company said on Thursday it had agreed to buy the targeted therapies division of Nordion Inc, for about $200 million in a deal that adds Therasphere radioactive glass beads treatment for liver cancer to its chemotherapy beads unit. ...


Pfizer takes its shot at a vaccine for evasive superbug
22 May 2013 at 10:28pm

By Julie Steenhuysen CHICAGO (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer. Jansen's next vaccine success could come by taming the superbug MRSA, a drug-resistant bacterium that she has seen ravage a healthy man up close and personally. Methicillin-resistant Staphylococcus aureus infects an estimated 53 million people globally and costs more than $20 billion a year to treat. ...



Alabama Mystery Illness Could Be Coincidence
22 May 2013 at 9:39pm

Alabama Illness Patients Have Little In Common


Teen birth rates decline in most US states
22 May 2013 at 9:21pm
The U.S. teen birth rate fell 25 percent over five years to a record low of 31 births per 1,000 teens ages 15 to 19, according to a report from the Centers for Disease Control and Prevention.

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC